The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Broker Offer to raise a maximum of £2.5m

27 Oct 2022 07:01

RNS Number : 2574E
Deepverge PLC
27 October 2022
 

DeepVerge PLC

 

("DeepVerge" or "Company")

 

Broker Offer to raise a maximum of £2.5m

 

· DeepVerge (AIM: DVRG) announces a Broker Offer through Turner Pope Investments (TPI) Limited. ("TPI")

· The Issue Price of the Broker Offer is 2 pence per New Ordinary Share.

· Every 4 (four) Broker Offer shares issued will have 1 (one) Placing Warrant attached, exercisable at 3 pence per Placing Warrant, for a period of 12 months from Admission of the Broker Offer shares.

· The Broker Offer has an initial expected value of £1.0 million, but may be extended to £2.5 million with the express agreement of the Company.

· Existing Shareholders or other interested parties who are qualified investors who wish to register their interest in participating in the Broker Offer should click on the following TPI platform link: DeepVerge - TPI Broker Offer (URL: https://forms.office.com/r/nptcgkst65)

· All bids communicated to TPI under the Broker Offer are subject to review and acceptance by the Company and TPI and priority will be given to Existing Shareholders in the event of oversubscription.

· The Broker Offer remains open until 4:30 p.m. on Friday, 28 October 2022.

· All Broker Offer shares will be issued subject to shareholders' approval at a General Meeting expected to take place on 14 November 2022.

 

Turner Pope Broker Offer

DeepVerge, the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, is pleased to announce that it wishes to provide Existing Shareholders and other investors who did not participate in the oversubscribed Fundraising announced today the opportunity to invest in the Company. Accordingly, under the Placing Agreement, TPI has been granted an option in the form of a Broker Offer under which TPI will, as agent for the Company, invite subscriptions for additional new Ordinary Shares with a value expected to be around £1.0 million at the Issue Price but which may be increased up to £2.5 million subject to agreement between TPI and the Company. Accordingly, the maximum number of New Ordinary Shares to be issued under the Broker Offer at the Issue Price is 125,000,000. The maximum number of Placing Warrants to be issued under the Broker Offer is 31,250,000.

 

The Broker Offer opens immediately and will close at 4.30 p.m. on Friday, 28 October 2022.

 

As far as is practical, participation in the Broker Offer will be prioritised for shareholders (direct or indirect) on the register at the close of business on 26 October 2022 ("Existing Shareholders"). If the expected maximum subscription under the Broker Offer is taken up, it will raise an additional £2.5 million, before expenses.

 

To subscribe for Broker Offer Shares, Existing Shareholders or other interested parties who are qualified investors who wish to register their interest in participating in the Broker Offer should click on the following link: DeepVerge - TPI Broker Offer (URL: https://forms.office.com/r/nptcgkst65)

A further announcement will be made following the end of the period during which the Broker Offer is open. If the Broker Offer is not fully subscribed by 4.30 p.m. on 28 October 2022, orders from eligible investors will be satisfied in full, and the balance of the Broker Offer shall lapse.

 

General Meeting

Completion of the Broker Offer is conditional on the relevant Resolutions being passed at the General Meeting, which is expected to take place on 14 November 2002. Admission of the Broker Offer Shares is expected on or around 16 November 2002. Further detail on the General Meeting and key dates for Admission of New Ordinary Shares are contained in the RNS detailing the Fundraising, also issued today, and will be available in the Circular to be published to the Company's website www.deepverge.com.

 

For further information, please contact:

 

DeepVerge plc

Ross Andrews, Chairman

+44 (0) 1904 40 4036

 

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited

(Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

 

Market Abuse Regulation (MAR) Disclosure

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFELEFMEESEFS
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - DEEPVERGE PLC
20th Dec 202312:30 pmRNSUpdate; exclusivity agreement with Microsaic
13th Dec 20234:38 pmRNSUpdate
14th Sep 20237:00 amRNSNew Website, Update
7th Aug 20232:30 pmRNSDisposal;Update; Related Party Trans'n-replacement
7th Aug 20237:00 amRNSDisposal; Update
2nd Aug 20239:35 amRNSBoard Change
1st Aug 20237:00 amRNSCompany Secretary Change
12th Jul 20237:00 amRNSUpdate
5th Jul 202311:26 amRNSUpdate
26th Jun 20237:30 amRNSSuspension - Deepverge PLC
26th Jun 20237:00 amRNSSale or closure of subsidiaries; share suspension
5th Jun 20237:00 amRNSCost reductions;delay to Ann. Report;New contract
19th Apr 20231:21 pmRNSMicrosaic Creditor; Update
17th Apr 20237:00 amRNS2022 revenue update - revision
24th Mar 202310:24 amRNSChange of Auditor
6th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20232:05 pmRNSSecond Price Monitoring Extn
6th Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSBoard Appointment
6th Feb 20235:30 pmRNSSignificant contract win and Board change
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNS2022 Revenue Update
23rd Nov 20224:10 pmRNSTR-1: Notification of major holdings
22nd Nov 20227:00 amRNSAccelerated Restructuring
16th Nov 20229:00 amRNSDirector/PDMR Shareholding
14th Nov 202212:16 pmRNSResult of Meeting
11th Nov 20224:37 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirectorate and Management Changes
3rd Nov 202212:32 pmRNSDirectorate Change
1st Nov 20223:56 pmRNSResult of Broker Offer; Total Voting Rights
31st Oct 20222:23 pmRNSBroker Offer to raise a max of £2.5m - replacement
31st Oct 20222:18 pmRNSExtension of Broker Offer to 430pm on 31 October
28th Oct 20221:06 pmRNSExtension of Broker Offer
27th Oct 20227:01 amRNSBroker Offer to raise a maximum of £2.5m
27th Oct 20227:00 amRNS£10m Placing, Broker Option, RPTs, Notice of GM
25th Oct 20222:05 pmRNSSecond Price Monitoring Extn
25th Oct 20222:00 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSUpdate - Proposed Financing,Proposed Board Changes
25th Oct 20227:00 amRNSHistorical Related Party Transactions
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
12th Oct 20227:04 amRNSResponse to Market Speculation
11th Oct 202211:05 amRNSSecond Price Monitoring Extn
11th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSLabskin contract
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.